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Abstract 1 
In this study, we investigated the expression of MUC1 mRNA and protein in sheep endometrium at 2 
different time-points during follicular and luteal phases of estrous cycle, and also determined the 3 
effect of steroid hormone treatments and interferon tau (IFNτ) on MUC1 mRNA expression in 4 
endometrial cell culture in vitro. In experiment 1, fifteen Welsh mountain ewes were synchronised to a 5 
common estrus and killed at precise stages of estrous cycle corresponding to i) pre-LH peak,  ii) LH 6 
peak,  iii) post-LH peak, iv) early luteal, and v) mid-luteal. Reproductive tracts were harvested and 7 
mRNA was extracted from the endometrial tissues. Parts of the uterine horns were fixed for 8 
immunohistochemistry. In experiment 2, mixed populations of ovine endometrial cells (from 9 
slaughterhouse material collected at the post-ovulatory stage of the estrous cycle) were cultured to 10 
70% confluence before treatment with i) progesterone (P4, 10 ng/mL, for 48 h), ii) oestradiol (E2, 100 11 
pg/mL, for 48 h), or with iii) E2 priming for 12 h (100 pg/mL) followed by P4 (10 ng/mL) for 36 h. 12 
These were compared to; iv) IFNτ (10 ng/mL, for 48 h), and v) basic medium (DMEM/F12) as 13 
control. The results showed that MUC1 mRNA and protein expression in sheep endometrium was 14 
highest during the mid-luteal stage and very low during the post-LH period compared with other 15 
stages (P<0.05). MUC1 immunostaining in the LE was apically restricted and was not significantly 16 
different across all stages of estrous cycle except at the post-LH peak where it was significantly low. 17 
In cell culture, MUC1 mRNA expression was significantly up-regulated by both steroids either singly 18 
or in combination (P<0.05), and down-regulated in the presence of IFNτ. In conclusion, endometrial 19 
MUC1 expression is cyclically regulated by both E2 and P4 in vivo and in vitro, and directly down-20 
regulated by IFNτ treatment in vitro. 21 
Key words: MUC1, endometrium, progesterone, estrogen, interferon tau  22 
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1. Introduction 23 
 
Mucin 1 (MUC1) is a membrane-bound O-glycosylated protein that is a member of the mucin family. 24 
It is expressed on the apical surface of mucosal epithelial cells and plays an essential role in forming 25 
protective mucous barriers on epithelial surfaces and is also involved in intracellular signalling. In the 26 
reproductive system, MUC1 is expressed in the uterus [1] and in the testes [2]. MUC1 has been linked 27 
to numerous functions [3] including antimicrobial effects by inhibiting microbial access to the cell 28 
surface as well as inhibition of cell-cell adhesion.   29 
In the uterus, successful implantation requires complex interaction between trophoblast and maternal 30 
endometrium. Available evidence suggests that the burden of implantation lies more on the 31 
endometrium rather than the embryo [4]. It has been shown that embryos are capable to attach to 32 
endometrial stromal cell culture and others tissues in vitro [5,6] however, embryos cannot attach to 33 
uterine endometrium outside the short period of window of receptivity [7]. Non-receptivity of 34 
endometrium has been partly attributable to features characteristic of luminal epithelia expressing 35 
glycocalyx, of which trans-membrane mucin 1 glycoprotein encoded by MUC1 gene is the most 36 
widely expressed and distributed in the reproductive tract [3].  37 
MUC1 protein is expressed mainly in luminal epithelium  (LE) and glandular epithelium (GE) of the 38 
endometrium in many mammalian species including mice, rat, pig, sheep, horse and human during 39 
various stages of a menstrual or estrous cycles [1, 8-11].  MUC1 is proposed to protect the 40 
reproductive system by preventing entrance of pathogens through the LE into endometrium [12]. It 41 
also constitutes an impediment to implantation by hindering interaction between families of 42 
conformationally smaller adhesion molecules such as integrins expressed on both the trophectoderm 43 
and LE [13]. In another perspective, this hindrance to implantation may be perceived as a 44 
physiological barrier that ensures only a potentially viable embryo successfully modulates 45 
endometrial receptivity and successfully implants. This hypothesis is supported by reduction of cell 46 
surface MUC1 in endometrium of women that experienced recurrent spontaneous abortion [14].  47 
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During implantation of the blastocyst to the endometrial epithelia, MUC-1 glycoforms in the 48 
endometrium which have been shown to carry selectin ligands [15] might mediate initial interaction 49 
with the L-selectin that is expressed on the trophectodermal surface of the blastocyst [16]. 50 
Subsequently it is essential that the MUC1 barrier is eliminated to create embryonic access to the 51 
uterine epithelium. In most mammalian species including sheep, this appears to be accomplished by 52 
down-regulation of MUC1 gene expression, at least locally.  53 
Ovarian steroids; progesterone and oestrogen, as well as the presence of embryo have been implicated 54 
in MUC1 regulation [1, 13] however MUC1 regulation seems not to follow a general pattern across 55 
all mammalian species and its regulation in the endometrium is therefore, species specific.  56 
MUC1 is down-regulated before implantation in the receptive endometrium of mice [17], rats [18], 57 
pigs [19] and sheep [10]. In contrast, MUC1 is upregulated in human endometrial at implantation [15] 58 
however human embryos seems to locally down-regulate MUC1 as shown in  maternal   primary 59 
endometrial cell culture in the region beneath embryo attachment points [1] suggesting regulatory 60 
roles of embryo-produced factors.  61 
In addition to steroid regulation of endometrial receptivity, INFτ which is secreted by trophoblast 62 
cells in ruminants is responsible for maternal recognition as it acts on uterine epithelium to down-63 
regulate estrogen and oxytocin receptors thus blocking the development of the uterine luteolytic 64 
mechanism [20]. Similar molecule is also produced by human embryos [21].  A progressive effort has 65 
been made towards understanding transcriptional regulation of MUC1 in reproductive tract [3], 66 
however, the mechanism remains to be completely understood. Besides, a direct effect of INFτ on 67 
MUC1 expression in sheep endometrium has not been tested. 68 
In the present study, we have investigated the temporal variation of MUC1 mRNA and protein 69 
expression in sheep endometrium during different stages of estrous cycle. To evaluate specific 70 
regulations, MUC1 mRNA expression was analysed in primary culture of ovine endometrial cells 71 
treated with steroid hormones or interferon-tau (IFNτ).  72 
 73 
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2. Material and Methods 74 
 75 
2.1. Experimental design 76 
 77 
All experimental procedures complied with regulations in the UK Animal (Scientific Procedures) Act, 78 
1986 and were conducted under a project licence which was approved by The Royal Veterinary 79 
College’s Ethics and Welfare Committee. In experiment 1, Mules ewes (n=15) of similar age (about 2 80 
years) were synchronised to a common estrus according to the method described earlier [22]. The 81 
animals were killed at precise time-points (n=3 each) as described below and reproductive tracts were 82 
harvested for mRNA extraction and immunohistochemistry for protein detection.  83 
In experiment 2, mixed endometrial cells were isolated from uteri obtained from abattoir as described 84 
in earlier study. The cells were seeded into 24-well plates at a concentration of 5 × 105 cells/well in 85 
DMEM.F12 media. At 70% confluence, they were supplemented with serum-free media for 24 h 86 
before treatment with one of the following: (i) P4 (10 ng/mL for 48 h), (ii) E2 (100 pg/mL for 48 h), 87 
(iii) E2 (100 pg/mL) for the first 12 h followed by P4 (10 ng/mL) for 36 h. This was compared to iv) 88 
Control  media or v) IFNτ treatment (10 ng/mL for 48 h, Genway, Oxfordshire, UK). IFNt treatment 89 
was used as a reference group since it is known to down-regulate MUC1 at the time of implantation 90 
[20], hence it was used to validate our culture system. At the end of each culture, media was removed. 91 
The cells were rinsed with cold PBS twice and total RNA was extracted. The treatments were done in 92 
three independent replicates. 93 
 
2.2. Experimental animals and synchronisation 94 
All 15 ewes received intravaginal Chronogest® sponges (Intervet UK ltd., Cambridge, UK) for 11 95 
days and treated with 300 IU of PMSG (Intervet UK Ltd, Buckinghamshire, UK) i.m. at the time of 96 
sponge removal. Estrus was observed 24 h after sponge removal. Blood samples were collected via 97 
jugular vein into 10 ml heparinized tubes at sponge removal and every 2 days until day 6, then every 98 
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day until the day of final slaughter. The animals were killed in a step-wise manner based on a 99 
previous study in our laboratory [23] at time-points corresponded to the following five stages of 100 
estrous cycle (i) pre-LH peak, (ii) LH peak, (iii) post-LH peak, (iv) early luteal and (v) mid-luteal, 101 
with three animals in each group as shown in Figure 1. Mid-luteal ewes were killed on day 8 of estrus 102 
(day 0 = estrus). The other 12 ewes received PGF2α injection (Estrumate; 125µg i.m) on day 11 of 103 
estrus at mid-night. Pre-LH ewes were killed at 32 h post PGF2α injection. The remaining 9 animals 104 
received GnRH (Receptal 1ml) at 36 h post PGF2α. LH-peak ewes were killed at 3 h post GnRH (39 h 105 
post PGF2α). Post-LH ewes were killed at 46 h post PGF2α (10 h post GnRH). Early luteal ewes were 106 
killed on 84 h post PGF2α administration.  107 
Blood samples were collected after PGF2α injection at the following time points; 0, 28, 30, 32, 34, 36, 108 
38, 39, 40, 42, 44, 46, 60, 72 and 84 h. They were centrifuged within few hours after collection and 109 
plasma were transferred to 7ml tubes and kept at -200C until the time for LH determination. The 110 
reproductive tracts were harvested. Small pieces of the endometrium were carefully dissected from 111 
the uterine horns and snap frozen for mRNA extraction and were used to determine MUC1 mRNA 112 
expression using conventional PCR. Sections of uterine horns were also fixed in 4% 113 
paraformaldehyde for immunohistochemistry.  114 
 
2.3. LH determination  115 
 116 
After 28 hours of PGF2α injection, blood was collected from all animals via the jugular vein at the 117 
hours 28, 30, 32, 34, 36, 38, 39, 40, 60 and 84 from the time of PGF2α injection. The time for each 118 
group was speculated prior to hormonal determination based on previuos works with the same drugs 119 
in sheep in our laboratory [24]. Plasma LH was determined (at the School of Human Development, 120 
University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH, UK) using radio-121 
immunoassay technique according to the method described in previous study [25]. The sensitivity of 122 
the assay was 0.15 ng/mL. 123 
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2.4. Endometrial cell isolation and culture  124 
 125 
The co-culture of both LE and ST where the two cells communicate and interact simulates the in vivo 126 
condition better than a monoculture of either LE or ST [26]. In addition, paracrine action of the S  127 
cells supports growth of LE cells [27]. Primary endometrial cells containing both uterine LE and 128 
Stromal (ST) cells were isolated and cultured following our previously optimized procedure [28]. 129 
Briefly, sheep endometrial luminal epithelia and stromal cells were isolated in a single digestion of 90 130 
min in 50 mL of digestive solution consisting of 25 mg of trypsin III (Roche, Welyn, UK), 25 mg of 131 
collagenase II (Roche), 50 mg of bovine serum albumin (BSA, Sigma). The isolated cells were plated 132 
at a concentration of 5 × 105 cells/mL and 1 mL of the cell suspension was added per well in a 24-well 133 
microplate (Iwaki, Scitech Div., Asahi Techno Glass) with Dulbecco Modified Eagle medium 134 
(DMEM/F12, Sigma) containing 10% foetal bovine serum. The plates were then incubated in a humid 135 
atmosphere at 37°C with 5% CO2. The culture media was changed every 48 h for 5-6 days until 70% 136 
confluence was achieved. This was followed by a 24 h incubation in serum-free media before 137 
treatment supplementation. The cell population was identified using cell morphology [29] and 138 
cytoskeletal markers, cytokeratin and vimentin for LE and ST respectively as was described in 139 
previous study [27]. The results showed a monolayer of a mixed population of epithelial and stromal 140 
cells in the ratio of 6:4.  141 
 
2.5. Primer design and RT-PCR 142 
 143 
The primers for MUC1 and a reference gene; GAPDH were designed using ‘primer 3’ web based 144 
software using ovine nucleotide coding sequences published in the National Centre for Biotechnology 145 
Information database (http://www.ncbi. nlm.nih.gov/Database/index.html). Primer alignment and 146 
specificity was checked using the BLAST search tool at the NCBI website (http://www.idtdna.com/ 147 
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analyzer/Applications/OligoAnalyzer/Default.aspx). Sequence information, accession numbers and 148 
expected product lengths as well as the running conditions of these primers are provided in Table 1. 149 
For the endometrial cell culture, total RNA was extracted using a column method (RNeasy Mini Kits; 150 
QIAGEN Ltd, West Sussex, UK) according to the manufacturer’s instruction (www.qiagen.com/goto/ 151 
microRNAprotocols). The procedures have been described in an earlier study [30]. The concentration 152 
and purity of the isolated RNA samples was determined with a NanoDrop ND-1000 153 
spectrophotometer (NanoDrop Technologies Inc., Wilmington, DE). All samples had an A260/280 154 
ratio of absorbance (A) between 1.8 and 2.1. The integrity of the RNA was confirmed by running it on 155 
a 1% formaldehyde gel to visualize the 18S and 28S rRNA bands. To eliminate potential genomic 156 
DNA carry over, 1 µg mRNA from each sample was treated in a single reaction with DNAse in 157 
accordance with manufacturer’s guideline (Promega Corporation, Madison, WI). DNase-treated RNA 158 
(1 µg) was reverse transcribed using Reverse Transcription System Kit (Promega) in a 20 µl reaction 159 
solution as was described in a previous study [31].  160 
The primers were used to run a conventional PCR using a Multiplex kit (Qiagen) according to 161 
manufacturer’s instruction in a 50 µl reaction containing the following; 25 µl Multiplex master mix, 162 
10 µl Q-solution, 5 µl primer (2 uM), 5 µl RNase-free water and 5 µl cDNA of the test sample. In the 163 
negative and positive control templates, the sample cDNA was replaced with nuclease-free water and 164 
cDNA from endometrial strips respectively. The reaction was run for 35 cycles on a thermal cycler 165 
(Techne PCR Machine TC312; Scientific Laboratory Supplies, Yorkshire, UK). The amplicons were 166 
visualized by electrophoresis on 1% agarose gels. The amplicon bands for MUC1 were quantified 167 
with AlfaEase software as reported in earlier study [32] and expressed as fold change compared to the 168 
control after initial normalisation with GAPDH. 169 
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2.6. MUC1 immunostaining and quantification 170 
 171 
MUC1 immunostaining was performed according to a standard IHC technique as previously 172 
described [31]. Briefly, the uterine sections of 5 µm in thickness were mounted on superfrost slides 173 
(VWR international Co., Leicestershire, UK) and rehydrated in a gradient of ethanol following 174 
dewaxing in clearing agent; Histoclear (Fisher Scientific, Loughborough, UK). Rabbit polyclonal 175 
Anti-MUC1 (Abcam, Cambridge) was used at a concentration of 2 µg/mL and incubated in a 176 
humidified chamber at 4°C overnight. A biotinylated anti-rabbit secondary antibody (Dako, Denmark, 177 
at 1:100) was then applied followed by Vectorstain ABC kit according to the manufacturer’s 178 
instructions (Vector Laboratories, Peterborough, UK). In the negative controls, the primary antibody 179 
was replaced with normal rabbit IgGs (Santa Cruz Biotechnology, Inc., Heidelberg, Germany) at the 180 
same concentration.   181 
The intensity of staining in the endometrial luminal epithelia was scored with the aid of a user-defined 182 
digital quantitative image analysis system (Volocity 5.5; PerkinElmer, Inc., MA, USA) as described 183 
and validated in an earlier study [33] and classified on a scale of 0 to 3, where 0 = negative staining, 1 184 
= weak staining, 2 = moderate staining, and 3 = strong staining. For statistical analysis, the expression 185 
level of MUC1 was evaluated using a Histology score (H-SCORE), from the intensity and area 186 
proportion scores using the following equation: H-score = [(1 × % area expression of score 1) + (2 × 187 
% area expression of score 2) + (3 × % area expression of score 3), giving a possible range of 0-300 188 
[34]. Each region was assessed based on at least 10 fields of digital format image taken at 400 × 189 
magnification with a light microscope. 190 
 
2.7. Statistical analysis 191 
 192 
Data are presented as mean ± SEM. All data were tested for homogeneity by Levene’s test and were 193 
normally distributed. Analysis was done using ANOVA with SPSS 18.0 for Windows (Chicago, IL, 194 
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USA). One way ANOVA was used to analyse the effect of stages of estrous cycle or treatment on 195 
MUC1 expression. If the treatment effect was significant, Bonferroni post hoc tests were performed 196 
for pairwise comparisons. Significance was established at P<0.05. 197 
 198 
3. Results  199 
 
3.1. LH profile  200 
 201 
The mean plasma LH profiles of all animals at different time points are presented in Fig. 2. The LH 202 
peak was evident at 39h after PGF2α injection which confirms successful synchronisation schedule 203 
and precise timing of sample collection. At the time of slaughter, the plasma LH concentrations were 204 
0.7 ± 0.07, 28.5 ± 4.5, 2.9 ± 0.8 and 0.6 ± 0.07 ng/mL for the Pre-LH peak, LH peak, Post-LH peak 205 
and Early-luteal groups respectively.  206 
Fig. 2 207 
 
3.2. MUC1 mRNA expression in sheep endometrium during different stages of estrous cycle 208 
 209 
MUC1 mRNA was expressed in the endometrial tissue in the pre-LH and LH peak stages at similar 210 
level (P>0.05). This was followed by a significant (P<0.01) transient reduction at the post-LH stage 211 
(Fig. 3). As the cycle entered into early luteal stage, there was a significant increase in the MUC1 212 
transcripts expression compared to the post-LH samples and similar to those at pre-LH and LH peak. 213 
Expression of MUC1 mRNA in the endometrium was maximum in the mid-luteal phase compared 214 
with other stages. 215 
Fig. 3 216 
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3.3. MUC1 protein expression in sheep endometrium during different stages of oestrous cycle 217 
 218 
MUC1 immunostaining in the LE was detected during all stages of estrous cycle at the apical surface 219 
of the LE and glandular epithelium (GE) cells. It was also observed that MUC1 protein protruded well 220 
above the cell surface of the LE. It was strongly present in the uterus at Pre-LH and LH stages as well 221 
as early and mid-luteal stages. In contrast, a significantly (P<0.05) lower staining intensity was 222 
observed in the post-LH group (Fig. 4). The negative control sections had no background staining. 223 
Fig. 4 224 
 225 
3.4. MUC1 expression in endometrial cells treated with steroids 226 
 227 
Supplementation with P4 and/or E2 increased MUC1 mRNA expression in the endometrial cell culture 228 
compared to the hormone-free control and IFNτ treatment (P<0.05, Fig. 5). A relative increment 229 
observed in the E2+P4 group was not significantly higher (P>0.05) than either P4 or E2 alone. 230 
Treatment with IFNτ resulted in a significant (P<0.05) reduction in MUC1 mRNA compared to the 231 
control and steroid treatments. 232 
Fig. 5 233 
 
4. Discussion 234 
 235 
In the present study, we evaluated the expression of MUC1 mRNA and protein in sheep endometrium 236 
at precise time-points during follicular and luteal phases of estrous cycle. This was further 237 
complemented with studying the effect of steroid hormones and INFτ on MUC1 mRNA expression in 238 
endometrial cell cultures in vitro. The results showed that MUC1 mRNA and protein expression in 239 
sheep endometrium were variably highly expressed during all stages of estrous cycle except a 240 
transient down-regulation at the post-LH peak stage. MUC1 expression in vitro was up-regulated in 241 
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the presence of one or both steroid hormones, and down-regulated by INFτ. 242 
Highest expression of MUC1 mRNA was seen during the luteal phase especially at the mid-luteal 243 
stage compared to other stages of estrous cycle. These stages correspond to the period of high plasma 244 
progesterone and its associated dominance in the endometrial LE. These results agree with previous 245 
reports of increased MUC1 expression under progesterone-dominated endometrial epithelium in 246 
rabbit [35] and human [1]. Interestingly, we could detect a significant drop in MUC1 mRNA 247 
expression at post LH peak stage which was also confirmed by immunostaining. This may be 248 
explained by low steroid concentrations at this time point. During post-LH peak, transition from 249 
follicular to luteal phases involves decreasing estrogen level to basal while progesterone level is still 250 
low. This is also consistent with our observation that the control endometrial cell cultures had lower 251 
MUC1 expression compared to those treated with P4 and/or E2. During the luteal phase, high 252 
MUC1immunostaining was previously reported at the apical surface of the uterine LE at Days 1, 3, 5, 253 
and 7 of the estrous cycle which was then decreased until Day 15 [10].  MUC1 expression after day 254 
15 and during the follicular phase of oestrous cycle was not examined in the later study [10]. We 255 
observed protrusion of MUC1 from the apical surface of the LE which is in agreement with earlier 256 
report of its being a trans-membrane protein with a large mucin-like extracellular domain, projecting 257 
so high above the cell surface beyond the region most common receptors are located [3]. 258 
The apical expression of MUC1 protein in the endometrial LE and GE observed in the present study is 259 
at par with the results of Johnson et al. [10].  In addition, our data has revealed a transient decline in 260 
MUC1 mRNA and protein expression at the post-LH in both regions providing further evidence for 261 
MUC1 dependency on steroid hormones [1]. This period coincides with the optimum insemination 262 
time in sheep. Therefore it is reasonable to conceptualise that the reduction in MUC1 may allow 263 
sperm interaction with endometrial epithelium during transport in the uterus and facilitate sperm 264 
capacitation or transport as was earlier suggested [36]. After copulation/insemination, sperm-265 
endometrial interactions are evident [37,38] and it is hypothesised in a recent review [39] that these 266 
interactions may play regulatory roles in induction of immunologic tolerance against paternal 267 
antigens, preparation of the endometrium for implantation and maintenance of pregnancy.  268 
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In the cell culture, both steroids caused a significant increase in MUC1 transcript expression. The 269 
relative increase in expression of MUC1 after initial priming of the endometrial cell with E2 prior to 270 
P4 treatment is understandable because E2 is known to up-regulate progesterone receptors (PR) [40] 271 
such that treatment with progesterone later produced a higher effect than individual steroids. This 272 
concurs with the finding of earlier study in human Ishikawa cell line [41]. In a related study, MUC1 273 
mRNA expression was higher in infertile women with ovulatory polycystic ovarian syndrome than 274 
fertile women [42]. 275 
In the present study, we found that exposure of endometrial cell culture to INFτ in the absence of 276 
steroids directly induce a reduction in MUC1 mRNA expression IFNτ concentration (1130 ng/mL) 277 
used here mimics the amount produced by day-8 harvested ovine embryo (11 ng/mL) after in vitro 278 
culture for 24 h [43]. Since IFNτ is the embryo signal of pregnancy in sheep [20], this result is at par 279 
with down-regulation of MUC1 by the human blastocyst through a paracrine signal especially at the 280 
region of implantation in human endometrial epithelial cells [1]. Similarly, the same observation (loss 281 
of MUC1) due to embryo signal was also observed in rabbit epithelia co-culture with blastocyst [35]. 282 
In the later study, loss of MUC1 from the epithelial surface was confined only to implantation sites 283 
(region directly beneath the blastocyst) while high level of MUC1 expression continued in non-284 
implantation regions. We did not study the interactions between INFτ and steroid hormones on MUC1 285 
expression in cell culture. It has been postulated that, in sheep, extended exposure of LE and GE cells 286 
to elevated progesterone levels result in down-regulation of progesterone receptors in LE and GE but 287 
not in stromal cells and was associated with a reduction in MUC1 expression [44]. Simulating these 288 
changes in vitro is difficult due to the complexity of the interaction between different cells types, cell 289 
differentiation and loss of specific functions during prolonged culture conditions. Nevertheless, our 290 
results simply suggest that ovine blastocysts can directly reduce MUC1 expression in endometrial 291 
cells which may play a novel regulatory role during embryo adhesion in sheep. 292 
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5. Conclusion 293 
 294 
We show evidence that MUC1 mRNA and protein expression in sheep endometrium are variably 295 
highly expressed both during the progesterone dominant luteal phase and the estrogen dominant 296 
follicular phase. We have also demonstrated that in vitro using endometrial cell cultures where either 297 
estrogen or progesterone supplementation up-regulated MUC1. The transition at post-LH peak stage 298 
was an exception where a transient down-regulation of MUC1 was observed both at mRNA and 299 
protein levels. The physiological role of this transient down-regulation during this period is yet to be 300 
investigated.  301 
 302 
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Figure Captions 308 
 309 
Fig. 1. Estrus synchronization and hormonal treatments of ewes and timing of sample 310 
collections.  Blood samples were collected at all time-points after PGF2α injection. A total of 15 ewes 311 
were used. Three ewes were sacrificed in each group 312 
Fig. 2.  LH concentration in blood samples collected at different time points during the 313 
experiment. Values are presented as Mean ± SEM. From 0-32h, n=12; 36-39h, n=9; 40-46h, n=6; 60-314 
84h, n=3. 315 
Fig. 3. Representative gel images of RT-PCR products for MUC1 and GAPDH in sheep 316 
endometrium during different stages of estrous cycle. Bands were quantified with Alpha EaseFC 317 
software and presented in the bar chart as mean±SEM. Legends: Lut; luteal, MUC1; mucin 1, 318 
GAPDH; glyceraldehyde 3-phosphate dehydrogenase. Estrous Bars with different superscripts are 319 
significantly different at a vs b or c P<0.01 or b vs c P<0.0.05  320 
Fig. 4. (A) Photomicrograph of MUC1 protein expression and (B) bar chart presentation of H-321 
Score with Volocity software.  Data are shown as mean ± SEM from ten different scored regions 322 
from each stage of estrous cycle (n=3 each). Significant difference is established at x vs y or z P 323 
<0.05; y vs z P <0.1.  324 
Fig.  5. (A) Representative gel image of MUC1 (upper panel) and GAPDH (lower panel) PCR 325 
products from endometrial cell culture treated with progesterone (P4), oestradiol (E2),  E2 + P4 326 
or interferon tau (IFNτ) and (B) bar chart presentation of band quantification with AlfaEase 327 
software. Expression of MUC1 mRNA was compared to the control after normalisation with GAPDH 328 
as the reference gene. Data are shown as mean ± SEM from three independent replicates. Different 329 
superscripts indicate significant difference at P < 0.05. 330 
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Table 1. Oliqonucleotide primer sequence information. Legend: MUC1; mucin 1, GAPDH; 
glyceraldehyde 3-phosphate dehydrogenase, A; adenine, C; cysteine. G; guanine, T; thiamine, Rev; 
reverse, FOR; forward 
Gene     Primer Sequence (5’- 3’) Size (bp) Accession no. 
Annealing 
Temp. 
MUC1 FOR:  CTCAGTCCCCAGCTCTGAAA 
REV:  GAGGCCCAGAAAATCCCTCT 
 252 NM_174115.2 60.0oC 
GAPDH FOR: CACTGTCCACGCCATCACT 
REV: GCCTGCTTCACCACCTTCT 
 267 NM_001190390.1 63.3oC 
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•         We studied regulation of MUC1 expression in endometrium during estrous and in vitro. 
• MUC1 was highly expressed at pre-LH peak, LH-peak and luteal phases 
•         MUC1 expression was reduced only at the post-LH peak period  
•         Estrogen and/or progesterone augmented  MUC1 expression in endometrial cell culture 
•         MUC1 expression was low in the absence of steroids as in the presence of IFN-tau 
 
